Skip to main content
Article thumbnail
Location of Repository

Association between disability measures and healthcare costs after initial treatment for acute stroke

By J. Dawson, J.S. Lees, T.P. Chang, M.R. Walters, M. Ali, S.M. Davis, H.C. Diener and K.R. Lees

Abstract

<p><b>Background and Purpose:</b> The distribution of 3-month modified Rankin scale (mRS) scores has been used as an outcome measure in acute stroke trials. We hypothesized that hospitalization and institutional care home stays within the first 90 days after stroke should be closely related to 90-day mRS, that each higher mRS category will reflect incremental cost, and that resource use may be less clearly linked to the National Institutes of Health Stroke Scale (NIHSS) or Barthel index.</p>\ud \ud <p><b>Methods:</b> We examined resource use data from the GAIN International trial comparing 90-day mRS with total length of stay in hospital or other institutions during the first 90 days. We repeated analyses using NIHSS and Barthel index scores. Relationships were examined by analysis of variance (ANOVA) with Bonferroni contrasts of adjacent score categories. Estimated costs were based on published Scottish figures.</p>\ud \ud <p><b>Results:</b> We had full data from 1717 patients. Length of stay was strongly associated with final mRS (P<0.0001). Each mRS increment from 0 to 1–2 to 3–4 was significant (mean length of stay: 17, 25, 44, 58, 79 days; P<0.0005). Ninety-five percent confidence limits for estimated costs (£) rose incrementally: 2493 to 3412, 3369 to 4479, 5784 to 7008, 7300 to 8512, 10 095 to 11 141, 11 772 to 13 560, and 2623 to 3321 for mRS 0 to 5 and dead, respectively. Weaker relationships existed with Barthel and NIHSS.</p>\ud \ud <p><b>Conclusions:</b> Each mRS category reflects different average length of hospital and institutional stay. Associated costs are meaningfully different across the full range of mRS outcomes. Analysis of the full distribution of mRS scores is appropriate for interpretation of treatment effects after acute stroke and more informative than Barthel or NIHSS end points.</p&gt

Publisher: American Heart Association
Year: 2007
OAI identifier: oai:eprints.gla.ac.uk:21074
Provided by: Enlighten

Suggested articles

Citations

  1. A prospective study of predictors of prolonged hospital stay and disability after stroke. doi
  2. (2007). Age Concern Scotland Factsheet FS10s. Age Concern Scotland. Available at: www.ageconcernscotland.org.uk/pdf.pl?fileage/news/ FS10sJul06.pdf. Accessed April 6,
  3. Assessment of functioning and disability after ischaemic stroke. doi
  4. Care needs and economic consequence after acute ischaemic stroke: the Erlangen Stroke Project. doi
  5. (1957). Cerebral vascular accidents in patients over the age of 60, II: prognosis. Scot Med J.
  6. Comparison of the NIHSS with disability outcome measures in acute stroke trials.
  7. (2004). Costs of stroke care according to handicap levels and stroke subtypes. Cerebrovasc Dis. doi
  8. for the GAIN International Investigators. Glycine Antagonist (gavestinel) doi
  9. Functional evaluation: the Barthel index. doi
  10. Hardemark HG, Wasiewski WW for the Stroke-Acute Ischemic-NXY Treatment (SAINT I) trial investigators. NXY-059 for acute ischaemic stroke. doi
  11. Health care resource use and stroke outcome: multinational comparisons within the GAIN trial. doi
  12. (2005). ISD Scotland. Available at: www.isdscotland.org/isd/information.jsp?pContentID3672&p_applic CCC&p_serviceContent.show&. Accessed
  13. Measurements of acute cerebral infarction: a clinical examination scale. doi
  14. Number needed to treat estimates incorporating effects over the entire range of clinical outcomes: novel derivation method and application to thrombolytic therapy for acute stroke. doi
  15. NXY-059 for acute ischemic stroke. doi
  16. (2006). NXY-059 for acute ischemic stroke. The promise of neuroprotection is finally realized? doi
  17. Resource utilisation and costs of stroke unit care in Germany. Value in Health. doi
  18. Strengthening acute stroke trials through optimal use of disability end points. doi
  19. (2004). The Atlas of Heart Disease and Stroke. Geneva: World Health Organization;

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.